In brief: All quinagolide strengths are being discontinued (75mcg by December 2026). Identify patients and seek specialist advice on alternatives.
🔒 For Birmingham LMC member practices
The full text of this ICB brief item is available to GPs and staff in Birmingham practices. Log in to read it, or get access with your nhs.net email.